Ratings Shanghai GenTech Co., Ltd.

Equities

688596

CNE1000043Q6

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
36.08 ^CNY	-4.65%		-7.49%	-8.96%

04-29	Shanghai GenTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-24	Tranche Update on Shanghai GenTech Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	CI

Strengths

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
The earnings growth currently anticipated by analysts for the coming years is particularly strong.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses

In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Industrial Machinery & Equipment

	1st Jan change	Capi.	ESG Refinitiv
SHANGHAI GENTECH CO., LTD.	-8.96%	1.39B	-
ATLAS COPCO AB	+16.68%	87.2B	A-
PARKER-HANNIFIN CORPORATION	+21.80%	72.13B	B
INGERSOLL RAND INC.	+18.00%	36.82B	B-
XYLEM INC.	+25.04%	34.67B	A
FANUC CORPORATION	+12.66%	28.34B	B-
FORTIVE CORPORATION	+4.41%	27.06B	C+
SANDVIK AB	+6.88%	26.98B	B+
TECHTRONIC INDUSTRIES CO. LTD.	+20.37%	26.3B	B+
DOVER CORPORATION	+20.64%	25.5B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes